RT Journal Article
SR Electronic
T1 Generation of novel SARS-CoV-2 variants on B.1.1.7 lineage in three patients with advanced HIV disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.14.21267836
DO 10.1101/2022.01.14.21267836
A1 Riddell, Anna C.
A1 Kele, Beatrix
A1 Harris, Kathryn
A1 Bible, Jon
A1 Murphy, Maurice
A1 Dakshina, Subathira
A1 Storey, Nathaniel
A1 Owoyemi, Dola
A1 Pade, Corinna
A1 Gibbons, Joseph M.
A1 Harrington, David
A1 Alexander, Eliza
A1 McKnight, Áine
A1 Cutino-Moguel, Teresa
YR 2022
UL http://medrxiv.org/content/early/2022/01/15/2022.01.14.21267836.abstract
AB The emergence of new SARS-COV-2 variants is of public health concern in case of vaccine escape. Described are three patients with advanced HIV-1 and chronic SARS-CoV-2 infection in whom there is evidence of selection and persistence of novel mutations which are associated with increased transmissibility and immune escape.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The chair of the research governance committee of Barts Health NHS Trust and Queen Mary University of London has waived ethical approval for this work on behalf of the committee.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study which is not included in the manuscript and supplementary material are available upon reasonable request to the authors http://cov-glue.cvr.gla.ac.uk/#/home